Anderson, A <br/><br/>
Genentech falls at the last fence in race to market heart drug.  [electronic resource] 

 -  Nature   
 - 450 p.  digital 
<br/><br/> Publication Type: News 
<br/><br/><label>ISSN: </label>0028-0836 
<br/><br/><label>Standard No.: </label>10.1038/327450a0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Drug Industry<br/>Humans<br/>Myocardial Infarction--drug therapy<br/>Recombinant Proteins--therapeutic use<br/>Tissue Plasminogen Activator--therapeutic use<br/>United States<br/>United States Food and Drug Administration